Dianthus Therapeutics, Inc. (DNTH)
41.43
+0.03
(+0.07%)
USD |
NASDAQ |
Dec 17, 16:00
41.42
-0.01
(-0.02%)
After-Hours: 20:00
Dianthus Therapeutics Total Assets (Quarterly): 577.44M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cytokinetics, Inc. | 1.437B |
| Lexicon Pharmaceuticals, Inc. | 205.93M |
| Day One Biopharmaceuticals, Inc. | 513.78M |
| CEL-SCI Corp. | 20.34M |
| AIM ImmunoTech, Inc. | 5.494M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.99M |
| Shareholders Equity (Quarterly) | 546.45M |
| Debt to Equity Ratio | 0.0024 |
| Current Ratio | 17.35 |
| Net Debt Paydown Yield | -0.01% |